| 產(chǎn)品標(biāo)題 |
產(chǎn)品貨號(hào) |
產(chǎn)品規(guī)格 |
廠家 |
| Proteinase K, Standard Grade from BIOVISION, INC. | 9250-500 | 500 mg | BIOVISION, INC. |
| Prostatic acid phosphatase, human recombinant from BIOVISION, INC. | P1066-10 | 10 μg | BIOVISION, INC. |
| Prostatic acid phosphatase, human recombinant from BIOVISION, INC. | P1066-50 | 50 μg | BIOVISION, INC. |
| eEF2, Rabbit Reticulocytes from BIOVISION, INC. | P1316-10 | 10 μg | BIOVISION, INC. |
| Lysozyme Inhibitor Screening Kit from BIOVISION, INC. | K237-100 | 100 assays | BIOVISION, INC. |
| Lys01 trihydrochloride from BIOVISION, INC. | B2117-5 | 5 mg | BIOVISION, INC. |
| Lys01 trihydrochloride from BIOVISION, INC. | B2117-25 | 25 mg | BIOVISION, INC. |
| PDTC from BIOVISION, INC. | 1676-100 | 100 mg | BIOVISION, INC. |
| Prostaglandin D2 (PGD2) ELISA Kit from BIOVISION, INC. | E4718-100 | 100 assays | BIOVISION, INC. |
| Orexin 2 Receptor Agonist from BIOVISION, INC. | B1124-25 | 25 mg | BIOVISION, INC. |
| Orexin 2 Receptor Agonist from BIOVISION, INC. | B1124-5 | 5 mg | BIOVISION, INC. |
| MEDICA 16 from BIOVISION, INC. | B2508-1 | 1 mg | BIOVISION, INC. |
| MEDICA 16 from BIOVISION, INC. | B2508-5 | 5 mg | BIOVISION, INC. |
| Carfilzomib from BIOVISION, INC. | 2385-5 | 5 mg | BIOVISION, INC. |
| Carfilzomib from BIOVISION, INC. | 2385-25 | 25 mg | BIOVISION, INC. |
| Nitric Oxide Cell-Based HTS Assay Kit from BIOVISION, INC. | K979-100 | 100 assays | BIOVISION, INC. |
| Nitric Oxide Colorimetric Assay Kit from BIOVISION, INC. | K262-200 | 200 assays | BIOVISION, INC. |
| Nitric Oxide Fluorometric Assay Kit from BIOVISION, INC. | K252-200 | 200 assays | BIOVISION, INC. |
| Muellerian-inhibiting Factor (AMH)(Human) ELISA Kit from BIOVISION, INC. | E4538-100 | 100 assays | BIOVISION, INC. |
| PI-8 Blocking Peptide from BIOVISION, INC. | 3748BP-50 | 50 μg | BIOVISION, INC. |
| PI9 Blocking Peptide from BIOVISION, INC. | 3544RBP-50 | 50 μg | BIOVISION, INC. |
| Pibrentasvir from BIOVISION, INC. | B2168-5 | 5 mg | BIOVISION, INC. |
| Pibrentasvir from BIOVISION, INC. | B2168-25 | 25 mg | BIOVISION, INC. |
| NADPH, tetrasodium salt from BIOVISION, INC. | 2738-50 | 50 mg | BIOVISION, INC. |
| NADPH, tetrasodium salt from BIOVISION, INC. | 2738-250 | 250 mg | BIOVISION, INC. |
| NADPH, tetrasodium salt from BIOVISION, INC. | 2738-1000 | 1 g | BIOVISION, INC. |
| NDSB-195 from BIOVISION, INC. | 2131-25G | 25 g | BIOVISION, INC. |
| NDSB-195 from BIOVISION, INC. | 2131-5G | 5 g | BIOVISION, INC. |
| NDSB-201 from BIOVISION, INC. | 2132-25G | 25 g | BIOVISION, INC. |
| NDSB-201 from BIOVISION, INC. | 2132-50G | 50 g | BIOVISION, INC. |
| NDSB-201 from BIOVISION, INC. | 2132-5G | 5 g | BIOVISION, INC. |
| NDSB-211 from BIOVISION, INC. | 2133-1G | 1 g | BIOVISION, INC. |
| NDSB-211 from BIOVISION, INC. | 2133-25G | 25 g | BIOVISION, INC. |
| NDSB-211 from BIOVISION, INC. | 2133-5G | 5 g | BIOVISION, INC. |
| NDSB-221 from BIOVISION, INC. | 2134-5G | 5 g | BIOVISION, INC. |
| NDSB-221 from BIOVISION, INC. | 2134-25G | 25 g | BIOVISION, INC. |
| NAIP Blocking Peptide from BIOVISION, INC. | 3228BP-50 | 50 μg | BIOVISION, INC. |
| PF-04691502 from BIOVISION, INC. | 2289-5 | 5 mg | BIOVISION, INC. |
| PF-04691502 from BIOVISION, INC. | 2289-25 | 25 mg | BIOVISION, INC. |
| PF-04981517 from BIOVISION, INC. | 2917-5 | 5 mg | BIOVISION, INC. |
| PF-04981517 from BIOVISION, INC. | 2917-25 | 25 mg | BIOVISION, INC. |
| PF-05212384 from BIOVISION, INC. | 9461-10 | 10 mg | BIOVISION, INC. |
| PF-05212384 from BIOVISION, INC. | 9461-50 | 50 mg | BIOVISION, INC. |
| PF-06291874 from BIOVISION, INC. | B2001-5 | 5 mg | BIOVISION, INC. |
| PF-06291874 from BIOVISION, INC. | B2001-25 | 25 mg | BIOVISION, INC. |
| PF-06409577 from BIOVISION, INC. | B2033-5 | 5 mg | BIOVISION, INC. |
| PF-06409577 from BIOVISION, INC. | B2033-25 | 25 mg | BIOVISION, INC. |
| PF-06447475 from BIOVISION, INC. | 9447-5 | 5 mg | BIOVISION, INC. |
| PF-06447475 from BIOVISION, INC. | 9447-25 | 25 mg | BIOVISION, INC. |
| PF-06463922 from BIOVISION, INC. | B1169-10 | 10 mg | BIOVISION, INC. |